As an “Interested individual” not a patient on medication for hypertension, I think Aktiia is a great idea - however my initial three months were giving me much higher readings than my independent cuff device - which I’ve used for a few years previously. This latest re initialisation in October though seems to have put me back in line with my other cuff device readings. The Aktiia device actually noted this recent calibration was very different from earlier ones and I redid it as instructed. There are other possible reasons why my overall BP has reduced recently but it is extremely coincidental that it correlates with this month’s calibration. I’ll be intrigued to see where it goes. Even if it’s not 100% accurate it must I hope be showing any trends in a relative way.
Claim your business profile now and gain access to all features and respond to customer reviews.
Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.
Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.See more
